Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Breast Cancer Res · 2007 · PMC2206726 · PMID 17686159

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Using the median as a cutoff value for HRGβ1 expression, there was also a trend towards a poorer prognosis for patients expressing higher levels of HRGβ1, although this trend did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.